Recent evidence suggests that cellular senescence plays a role in promoting fibrosis, especially in aged tissues, where stress-induced senescent myofibroblasts may exhibit delayed clearance with age
5 is available in the PDB under accession codes 3D4K
Clinical trials on DSIP have produced mixed results
The FDAs position, stated explicitly in warning letters, is that RUO disclaimers are a ruse to avoid FDA scrutiny. If a product is being marketed in a way that implies human use through claim language, testimonials, dosing guidance, or the product category itself the disclaimer is legally irrelevant
Why supervision matters: Dosing, monitoring, and side effect management ensure both safety and success
OpenLoop Healthcare Partners, PC and affiliated licensed providers make all clinical decisions